Journal Home
Search for

Volume 57, Issue 2, Pages 195-200 (August 2004)


View previous. 6 of 18 View next.

The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis

Anja WittkowskiCorresponding Author Informationaemail address, Helen L. Richardsbc, Christopher E.M. Griffithsc, Chris J. Mainb

Received 16 July 2002; accepted 12 August 2003.

Abstract 

Objective

The aim of the study was to assess the influence of general and dermatitis-specific psychological and clinical factors on quality of life in adults with atopic dermatitis (AD).

Method

A total of 125 adults recruited through the National Eczema Society of U.K. (NES) completed a number of psychological and dermatological questionnaires, including the Dermatology Life Quality Index (DLQI), the Stigmatisation and Eczema Questionnaire (SEQ), the Hospital Anxiety and Depression Scale (HADS), the Fear of Negative Evaluation Scale (FNE) and the Rosenberg Self-Esteem Scale (RSE).

Results

Pearson's correlational analyses suggested that perceptions of stigma were significantly associated with psychological factors as well as quality of life (Ps<.01). An association was also found between perceived stigma and disease severity (−.28, P<.01). Almost 46% of participants were identified as having probable mood disorder. Regression analysis indicated that perceptions of stigma and depression accounted for 44.5% of the variance in quality of life in this sample [F(3,121)=34.18, P<.001], when disease severity was controlled for.

Conclusion

Psychological factors and disease severity were strong predictors of quality of life in adults with AD. AD-related perceptions of stigma were of particular importance in predicting AD-related quality of life over and above more general psychological factors, such as depression. These findings have important implications for the psychological and clinical management of AD.

a Academic Division of Clinical Psychology, School of Psychiatry and Behavioural Sciences, University of Manchester, 2nd Floor Education and Research Centre, Wythenshawe Hospital, Manchester M23 9LT, UK

b Department of Behavioural Medicine, Hope Hospital, Salford Royal Hospitals NHS Trust, Manchester, UK

c Dermatology Centre, School of Medicine, University of Manchester, Hope Hospital, Salford Royal Hospitals NHS Trust, Manchester, UK

Corresponding Author InformationCorresponding author. Tel.: +44-161-291-5881; fax: +44-161-291-5882

PII: S0022-3999(03)00572-5

doi:10.1016/S0022-3999(03)00572-5


View previous. 6 of 18 View next.